Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Uterine Cervical Neoplasms × Dasatinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17 Breast Neoplasms 15 Leukemia 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Leukemia, Myeloid, Chronic-Phase 10 Recurrence 8 Prostatic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 7 Neoplasm Metastasis 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Melanoma 5 Burkitt Lymphoma 5 Pancreatic Neoplasms 4 Leukemia, Myeloid, Acute 4 Glioblastoma 4 Blast Crisis 4 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 3 Neoplasms 3 Lymphoma 3 Gliosarcoma 3 Sarcoma 2 Salivary Gland Neoplasms 2 Rhabdomyosarcoma 2 Rectal Neoplasms 2 Polycythemia Vera 2 Oligodendroglioma 2 Multiple Myeloma 2 Lymphoma, Large B-Cell, Diffuse 2

Interventions

Cisplatin 32 human papillomavirus vaccine, L1 type 16, 18 16 Brachytherapy 15 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 12 Paclitaxel 11 Bevacizumab 11 pembrolizumab 9 Platinum 9 1,2-diaminocyclohexaneplatinum II citrate 9 Topotecan 8 Radiotherapy, Intensity-Modulated 8 Radiation 8 Papillomavirus Vaccines 8 atezolizumab 6 Gemcitabine 6 Fluorodeoxyglucose F18 6 Cyclophosphamide 6 tisotumab vedotin 5 fludarabine phosphate 5 fludarabine 5 aldesleukin 5 Taxes 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Carboplatin 5 Vaccines, Synthetic 4 Nivolumab 4 Immunoglobulin G 4 Disulfides 4 Colposcopy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡